ATC Group: J01C Beta-lactam antibacterials, penicillins

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J01C in the ATC hierarchy

Level Code Title
1 J Antiinfectives for systemic use
2 J01 Antibacterials for systemic use
3 J01C Beta-lactam antibacterials, penicillins

Group J01C contents

Code Title
J01CA Penicillins with extended spectrum
J01CE Beta-lactamase sensitive penicillins
J01CF Beta-lactamase resistant penicillins
J01CG Beta-lactamase inhibitors
J01CR Combinations of penicillins, incl. beta-lactamase inhibitors

Active ingredients in J01C

Active Ingredient

Amoxicillin is a semisynthetic penicillin (beta-lactam antibiotic) that inhibits one or more enzymes (often referred to as penicillin-binding proteins, PBPs) in the biosynthetic pathway of bactericidal peptidoglycan, which is an integral structural component of the bacterial cell wall. Inhibition of peptidoglycan synthesis leads to weakening of the cell wall, which is usually followed by cell lysis and death.

Ampicillin is a broad spectrum penicillin, indicated for the treatment of a wide range of bacterial infections caused by ampicillin sensitive organisms.

Semisynthetic antibiotic prepared by combining the sodium salt of penicillin G with N,N'-dibenzylethylenediamine. Benzathine benzylpenicillin binds to penicillin binding proteins (PBP), the enzymes that catalyze the synthesis of peptidoglycan, a critical component of the bacterial cell wall. This leads to the interruption of cell wall synthesis, consequently leading to bacterial cell growth inhibition and cell lysis.

Benzylpenicillin is a beta-lactam antibiotic. It is bacteriocidal by inhibiting bacterial cell wall biosynthesis. Penicillin resistance can be mediated by alteration of penicillin binding proteins or development of beta-lactamases.

Carbenicillin is a semisynthetic penicillin. Carbenicillin exerts its antibacterial activity by interference with final cell wall synthesis of susceptible bacteria. Most Klebsiella species are usually resistant to the action of carbenicillin.

Clavulanic acid is a beta-lactam structurally related to penicillins. It inactivates some beta-lactamase enzymes thereby preventing inactivation of amoxicillin.

Cloxacillin is a semi-synthetic beta-lactamase resistant penicillin with activity against gram-negative and gram-positive bacteria including beta-lactamase producing staphylococci. Cloxacillin acts by interfering with the formation of new bacterial cell wall by dividing organisms.

Dicloxacillin is a penicillinase stable, acid-stable semisynthetic penicillin. It inhibits bacterial cell wall synthesis and has bactericidal effect on penicillin susceptible bacteria in the growth phase.

Flucloxacillin is an isoxazolyl penicillin of the β-lactam group of antibiotics which exerts a bactericidal effect upon many Gram-positive organisms including β-lactamase-producing staphylococci and streptococci.

Phenoxymethylpenicillin is a broad spectrum beta-lactam antibiotic. Phenoxymethylpenicillin binds to penicillin-binding proteins located on the inner membrane of the bacterial cell wall. Phenoxymethylpenicillin binds to and inactivates these proteins resulting in weakening of the bacterial cell wall and lysis.

Piperacillin is a broad-spectrum, semisynthetic penicillin. Piperacillin exerts bactericidal activity by inhibition of both septum and cell-wall synthesis.

Pivmecillinam is an orally active antibiotic. It is the pivaloyloxymethylester of the amidinopenicillanic acid, mecillinam. Mecillinam is a betalactam with a narrow-spectrum of activity. It is mainly active against Gram-negative bacteria and works by interfering with the biosynthesis of the bacterial cell wall.

Sultamicillin is the tosylate salt of the double ester of sulbactam plus ampicillin. Sulbactam is a semisynthetic beta-lactamase inhibitor which, in combination with ampicillin, extends the antibacterial activity of the latter to include some beta-lactamase-producing strains of bacteria that would otherwise be resistant.

Tazobactam is a beta-lactam structurally related to penicillins. It is an inhibitor of many molecular Class A beta-lactamases, including CTX-M, SHV, and TEM enzymes.

Ticarcillin disrupts bacterial cell wall development by inhibiting peptidoglycan synthesis and/or by interacting with penicillin-binding proteins.

Related product monographs

Document Type Information Source  
 ACTIMENTIN Powder for oral suspension MPI, Generic Health Products Regulatory Authority (ZA)
 AMOXAPEN Film-coated tablet MPI, EU: SmPC Υπουργείο Υγείας (CY)
 AMOXIL Capsule MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 AUGMENTIN Powder for suspension / Film coated-tablet MPI, US: SPL/PLR FDA, National Drug Code (US)
 BETAMOX Capsule, Suspension MPI, Generic Health Products Regulatory Authority (ZA)
 BICILLIN L-A Suspension for injection MPI, US: SPL/Old FDA, National Drug Code (US)
 CLAVOMID 250 mg/125 mg Film-coated tablet MPI, EU: SmPC Υπουργείο Υγείας (CY)
 CLAVOMID 500 mg/125 mg Film-coated tablet MPI, EU: SmPC Υπουργείο Υγείας (CY)
 CURAM Powder for oral suspension / Film-coated tablet MPI, Generic Health Products Regulatory Authority (ZA)
 EDAMOX Hard capsule MPI, EU: SmPC Υπουργείο Υγείας (CY)
 FLOXAPEN Powder for solution for injection / infusion MPI, EU: SmPC Health Products Regulatory Authority (IE)
 MONOCLOX Powder for solution for injection or infusion MPI, EU: SmPC Υπουργείο Υγείας (CY)
 MOXARIN Capsule, hard MPI, EU: SmPC Υπουργείο Υγείας (CY)
 MOXILEN Capsule, Powder for oral suspension, Powder for solution for injection MPI, EU: SmPC Υπουργείο Υγείας (CY)
 NEGABAN Powder for solution for injection/infusion MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 OSPAMOX Powder for oral suspension / Paediatric drops MPI, EU: SmPC Medicines and Medical Devices Safety Authority (NZ)
 PAMECIL Hard capsule MPI, EU: SmPC Υπουργείο Υγείας (CY)
 PAMECIL Powder for solution for injection or infusion MPI, EU: SmPC Υπουργείο Υγείας (CY)
 PENOPEN Film-coated tablet MPI, EU: SmPC Υπουργείο Υγείας (CY)
 SYNTOCLAV Film-coated tablet, Powder for oral suspension MPI, EU: SmPC Υπουργείο Υγείας (CY)
 SYNTOCLAV Powder for solution for injection or infusion MPI, EU: SmPC Υπουργείο Υγείας (CY)
 TAZOCIN Powder for solution for infusion MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 ULTRAMOX Capsule MPI, Generic Marketing Authorisation Holder
 UNASYN Powder for solution for injection MPI, US: SPL/Old FDA, National Drug Code (US)